LanzaTech Global, Inc. LNZA
Nasdaq · XNAS · stock · Industrial Organic Chemicals · website · IPO 2021-08-06
LanzaTech Global, Inc. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $55.8M | $49.6M | $62.6M | $37.3M | — |
| R&D expense | $53.2M | $77.0M | $68.1M | $53.2M | — |
| SG&A expense | $47.0M | $50.0M | $50.4M | $26.8M | — |
| Operating income | -$79.2M | -$108.9M | -$106.4M | -$75.6M | -$1.4M |
| Income tax | $0 | $0 | $0 | $0 | $0 |
| Net income | -$49.0M | -$137.7M | -$134.1M | -$76.4M | $46,738 |
| EPS (diluted) | $-22.27 | $-69.71 | $-0.79 | $-12.37 | — |
| Operating cash flow | -$64.9M | -$89.1M | -$97.3M | -$84.7M | -$510,017 |
| Free cash flow | -$66.1M | -$94.4M | -$105.8M | -$95.4M | — |
| Cash & equivalents | $13.2M | $43.5M | $75.6M | $83.0M | $343,399 |
| Inventory | $684,000 | $2.2M | $1.8M | $1.1M | — |
| Total assets | $100.2M | $174.7M | $241.6M | $176.9M | $150.9M |
| Total liabilities | $90.9M | $161.2M | $127.2M | $124.9M | $11.6M |
| Shareholders' equity | -$3.9M | $13.4M | $114.5M | -$428.7M | -$354.9M |
Source: SEC EDGAR filings · CIK 0001843724 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.